Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8712 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8477 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8456 |
Intermediate Similarity |
NPD9494 |
Approved |
0.8356 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD6190 |
Approved |
0.8289 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8182 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.8151 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8143 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.8108 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8099 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.8085 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.8085 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.8039 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8028 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7973 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7972 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7949 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7943 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7905 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7881 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7877 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7875 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7875 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7875 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7863 |
Intermediate Similarity |
NPD228 |
Approved |
0.7852 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7843 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7838 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7785 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7748 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7744 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7742 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7742 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7724 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7721 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7703 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7698 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7697 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7669 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7651 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7651 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7639 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7613 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7612 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7593 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7591 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7589 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7584 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7571 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7571 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7568 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7562 |
Intermediate Similarity |
NPD919 |
Approved |
0.7557 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7533 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7532 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7531 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7517 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7515 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.75 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7484 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7483 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7482 |
Intermediate Similarity |
NPD17 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7453 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.745 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7421 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7417 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7415 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7415 |
Intermediate Similarity |
NPD943 |
Approved |
0.7415 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7413 |
Intermediate Similarity |
NPD2797 |
Approved |
0.74 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7384 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7362 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7355 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7348 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7324 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.732 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7313 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7313 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7312 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7305 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7303 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7297 |
Intermediate Similarity |
NPD826 |
Approved |
0.7297 |
Intermediate Similarity |
NPD825 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7296 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7286 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7286 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7284 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7278 |
Intermediate Similarity |
NPD824 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7256 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7256 |
Intermediate Similarity |
NPD2821 |
Approved |
0.725 |
Intermediate Similarity |
NPD37 |
Approved |
0.7248 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7241 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7241 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7237 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7237 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7234 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7233 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7226 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7222 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD4413 |
Clinical (unspecified phase) |
0.7215 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7208 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7203 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7195 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7188 |
Intermediate Similarity |
NPD958 |
Approved |
0.7181 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7181 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7181 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7174 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7172 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7171 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7171 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7171 |
Intermediate Similarity |
NPD2531 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7163 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7161 |
Intermediate Similarity |
NPD2309 |
Approved |
0.716 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7153 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7124 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7111 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7103 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7102 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD3274 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD2897 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD9493 |
Approved |
0.707 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7067
|
Intermediate Similarity |
NPD3140 |
Approved |